Equity

Company Snapshot Home > Equity > Corporate Information > Company Snapshot

Bliss GVS Pharma LtdIndustry : Pharmaceuticals - Indian - Formulations
BSE Code:506197 P/E (TTM) :24.57
ISIN Demat:INE416D01022 Div & Yield %:0.27 EPS (TTM) :7.41
Book Value (RS) :104.3299482 Market Cap (Rs Cr.):1926.42 Face Value (RS) :1
    Change Company 
Stock Price Details Chart
Last Price (RS) 176.20 
Change (%) -5.90 (-3.24%) 
Best Buy (RS) 0(x0) 
Best Sell (RS) 0(x0) 
Today's Range (RS) 172.00 - 182.45 
52-Week Range (RS) 105.05 - 195.85 
Beta (1 Year) 1.10 
| | | |
Index Details
BSE HC, BSE SmallCap
News Corporate Details
Bliss GVS Pharma consolidated net profit rises 12.32% in the September 2025 quarter
Bliss GVS Pharma Ltd leads losers in 'B' group
Bliss GVS Pharma schedules board meeting
Bliss GVS Pharma Ltd - Bliss GVS Pharma Limited - Pendency of Litigation(s)/dispute(s) or the outcome impacting the Comp...
Bliss GVS Pharma Ltd - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
Bliss GVS Pharma Ltd - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
Bliss GVS Pharma Ltd - Bliss GVS Pharma Limited - Allotment of Securities
Bliss GVS Pharma Ltd - Bliss GVS Pharma Limited - Allotment of Securities
Bliss GVS Pharma Ltd - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
Bliss GVS Pharma Ltd - Bliss GVS Pharma Limited - Copy of Newspaper Publication
Incoporation Year :  1984
Chairman : Nandkumar Kashinath Chodankar
Ownership Group : Indian Private
Sector : MAN
Industry : Pharmaceuticals - Indian - Formulations
Registered Office
Bliss GVS Pharma Ltd
102 Hyde Park Sakivihar Road,
Andheri East,
Mumbai,
Maharashtra-400072
Phone:91-22-42160000
Fax:91-22-28563930
E-Mail : cs@blissgvs.com; info@blissgvs.com
URL : http://www.blissgvs.com
Investor Returns
  Date Price Returns (%)
1Week 01-Jan-2026 162.00 12.41
1Month 08-Dec-2025 160.80 13.25
3Month 08-Oct-2025 152.10 19.72
6Month 08-Jul-2025 161.00 13.11
1Year 08-Jan-2025 174.90 4.12
Mutual Funds Holding
Scheme Name % Holding Market Value (Rs Cr.)
Motilal Oswal BSE Healthcare ETF 0.08 0.03
Bandhan BSE Healthcare Index Fund 0.08 0.01
Groups : Pharmaceuticals - Indian - Formulations
Company Last Price Change (%) 52Week High 52Week Low Market Cap (Rs Cr.)
Torrent Pharmaceuticals Ltd 3,960.00 -1.62 4,105.85 2,891.45 136,227.67
Ajanta Pharma Ltd 2,760.80 -2.61 3,065.45 2,022.05 35,415.50
Gland Pharma Ltd 1,680.00 -1.12 2,130.00 1,200.00 27,991.29
ERIS Lifesciences Ltd 1,501.60 -2.12 1,909.55 1,130.05 20,896.35
Sai Life Sciences Ltd 920.85 -4.10 983.60 635.30 20,283.48

FOR GRIEVANCE MAIL TO invgrieviss@iseindia.com

BSE EQUITIES : INB011077733 | NSE F&O EQUITIES : INF231077737 | NSE CASH MARKET : INB231077737 | NSE CURRENCY DERIVATIVES : INE231077737 | MCX-SX : INE261077737

ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited], a wholly owned subsidiary of Inter-connected Stock Exchange of India Ltd. (ISE)

© 2013 ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited]. All rights reserved.

Designed, developed & powered by C-MOTS Infotech (ISO 9001:2008 certified)